Kamel El-Attar

Head of Medical Affairs for Acute Therapies
Baxter ECEMEA

Graduated Cairo University, Faculty of Medicine with Honors in 2001. Received my Master’s Degree in Internal Medicine & Nephrology, Cairo University, with High Honors in 2007. Worked as a Nephrology Specialist for 8 years and was appointed Ass. Lecturer of Medicine at Theodor Bilharz Research Institute, Cairo in 2007.  Researched in the fields of ESRD, Endothelial Cell Dysfunction & Biomarkers. MBA with Distinction from Edinburgh Business School, UK in 2015. Lecturer of Critical Care Nephrology at World Kidney Academy (2024)

Currently Head of Medical Affairs for Acute Therapies at Vantive Limited,  covering ECEMEA. Member of the Egyptian Society of Nephrology & Transplantation since 2007. Speaker at the Syrian Society of Nephrology (2008), Macedonian Medical Association Society of Nephrology (2012), Kenyan Renal Association (2012,17,18), Egyptian Society of Pediatric Nephrology & Transplantation (2015), Nigerian Association of Nephrology (2017), Health Council of Serbia (2019), Emirates Critical Care Conference (2019, 20, 22-24), Turkish Society for Critical Care (2020), Lithuanian Society of Anesthesiology & Intensive Care (2020,21,23), Russia Sepsis Forum (2021), Association of Latvian Nephrologists (2020,21),  Timisoara Congress in Romania (2022), Romanian Society of Intensive Care Medicine SRAATI (2024), Saudi Critical Care Society (2022), KHUH Critical Care Congress in Bahrain (2023). Saudi Commission for Health Specialties (2022,23). CSARIM in Czech Republic (2024). Topics of interest include CRRT, AKI, ECBP, TPE, PD, ECCO2R.

Proud father of two boys and hobbies include traveling & sports.